Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early Mechanisms of Chemoresistance in Retinoblastoma
Michelle G. Zhang, Jeffim N. Kuznetsoff, Dawn A. Owens, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4966-4966
Open Access | Times Cited: 13

Showing 13 citing articles:

Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances
Merve Kulbay, Nicolas Tuli, M. R. Mazza, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 108-108
Open Access
The Role of Small Extracellular Vesicles in Retinoblastoma Development and Progression
Jyothi Attem, Geeta K. Vemuganti
Current Eye Research (2025), pp. 1-15
Closed Access
Enhancement of vincristine sensitivity in retinoblastoma through Janus kinase inhibition by ruxolitinib
Ke Feng, Nan Wang, Xuan Zhang, et al.
Anti-Cancer Drugs (2024)
Closed Access | Times Cited: 2
Fatty acid conjugated EPI-X4 derivatives with increased activity and in vivo stability
Mirja Harms, André Haase, Armando Rodríguez, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 583-598
Open Access | Times Cited: 2
GIPR Overexpression Reduces the Tumorigenic Potential of Retinoblastoma Cells
André Haase, Emily Alefeld, Fatma Yalinci, et al.
(2024)
Open Access | Times Cited: 1
Single-cell sequencing in primary intraocular tumors: understanding heterogeneity, the microenvironment, and drug resistance
Linfeng He, Pei Mou, Chunhui Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Research Progress on Platinum Resistance Mechanism and Resistance Therapy in Retinoblastoma
应洁 罗
Advances in Clinical Medicine (2024) Vol. 14, Iss. 01, pp. 1877-1887
Closed Access
Gastric Inhibitory Polypeptide Receptor (GIPR) Overexpression Reduces the Tumorigenic Potential of Retinoblastoma Cells
André Haase, Emily Alefeld, Fatma Yalinci, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1656-1656
Open Access
Single-Cell RNA Sequencing Reveals Transcriptional Signatures and Cell-Cell Communication in Diabetic Retinopathy
Muye Li, Yue-Ling Peng, Lin Pang, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2024) Vol. 24, Iss. 14, pp. 1651-1663
Closed Access
Clinical Facts on Retinoblastoma
Tobias Achu Muluh
Clinical Cancer Drugs (2024) Vol. 10
Closed Access
IGF2BP3‐dependent N6‐methyladenosine modification of USP49 promotes carboplatin resistance in retinoblastoma by enhancing autophagy via regulating the stabilization of SIRT1
Lei Li, Ning Yang, Jianhe Sun, et al.
The Kaohsiung Journal of Medical Sciences (2024)
Open Access
Mimicking Retinoblastoma Treatment With Repeated Topotecan or Melphalan Develops Cross-Resistance to Classic Agents But Not to Repurposed Drugs
María Belén Cancela, Ursula Winter, Santiago Zugbi, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 14, pp. 14-14
Open Access
[Cigarette Smoke Induces Gefitinib Resistance in NSCLC Cells 
via ROS/Sirt3/SOD2 Pathway].
Yawan Zi, Ke Liao, Hong Chen
PubMed (2023) Vol. 26, Iss. 4, pp. 245-256
Closed Access
Page 1

Scroll to top